GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (OTCPK:CNTMF) » Definitions » Inventory-to-Revenue

CNTMF (Cansortium) Inventory-to-Revenue : 0.65 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cansortium Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cansortium's Average Total Inventories for the quarter that ended in Sep. 2024 was $17.0 Mil. Cansortium's Revenue for the three months ended in Sep. 2024 was $26.1 Mil. Cansortium's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.65.

Cansortium's Inventory-to-Revenue for the quarter that ended in Sep. 2024 increased from Jun. 2024 (0.54) to Jun. 2024 (0.65)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cansortium's Days Inventory for the three months ended in Sep. 2024 was 106.63.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cansortium's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.86.


Cansortium Inventory-to-Revenue Historical Data

The historical data trend for Cansortium's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cansortium Inventory-to-Revenue Chart

Cansortium Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventory-to-Revenue
Get a 7-Day Free Trial 0.28 0.17 0.15 0.13 0.10

Cansortium Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.36 0.43 0.54 0.65

Competitive Comparison of Cansortium's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cansortium's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cansortium's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cansortium's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cansortium's Inventory-to-Revenue falls into.



Cansortium Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cansortium's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (A: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )
=( (9.969 + 9.575) / 2 ) / 97.29
=9.772 / 97.29
=0.10

Cansortium's Inventory-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue (Q: Sep. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2024 ) + Total Inventories (Q: Sep. 2024 )) / count ) / Revenue (Q: Sep. 2024 )
=( (17.679 + 16.37) / 2 ) / 26.147
=17.0245 / 26.147
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cansortium  (OTCPK:CNTMF) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cansortium's Days Inventory for the three months ended in Sep. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2024 )/Cost of Goods Sold (Q: Sep. 2024 )*Days in Period
=17.0245/14.569*365 / 4
=106.63

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cansortium's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2024 ) / Average Total Inventories (Q: Sep. 2024 )
=14.569 / 17.0245
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cansortium Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cansortium's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cansortium Business Description

Traded in Other Exchanges
Address
82 North East 26th Street, Unit 110, Miami, FL, USA, 33137
Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Cansortium Headlines

From GuruFocus

Q4 2023 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 04-30-2024

Cansortium Reports Third Quarter 2024 Results

By PRNewswire 11-29-2024

Q4 2020 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2019 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2022 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Cansortium Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024